Cortisol Synthesis Inhibitor [EPC] - N0000193935

Pharmacologic Class Information

Pharmacologic Code N0000193935
Pharmacologic Name Cortisol Synthesis Inhibitor
Pharmacologic Uses
  • cortisol synthesis inhibitor
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Cortisol Synthesis Inhibitor

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Cortisol Synthesis Inhibitor [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
55292-320Isturisa Non-Proprietary Name: OsilodrostatTablet, CoatedOralRecordati Rare Diseases, Inc.ACTIVE
55292-321Isturisa Non-Proprietary Name: OsilodrostatTablet, CoatedOralRecordati Rare Diseases, Inc.ACTIVE
72065-003Recorlev Non-Proprietary Name: LevoketoconazoleTabletOralXeris Pharmaceuticals, Inc.ACTIVE